Conbercept: Clinical Trials

21 trials of Conbercept, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 unknown, 7 completed, 1 active not recruiting, 1 recruiting. 6 Phase 4, 5 Phase 2, 4 Not applicable, 3 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 46Completed 3, Unknown 2, Active not recruiting 1
Phase 25Unknown 4, Completed 1
Not applicable4Unknown 2, Completed 1, Recruiting 1
Early Phase 13Unknown 2, Completed 1
Phase 31Unknown 1

Follow Conbercept: new trials by email Literature Review of Conbercept trials Research Report on Conbercept

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biological Changes in Fibrovascular Membranes of Patients With Proliferative Diabetic Retinopathy Following Faricimab Injection
conbercept ophthalmic injection (0.5mg), Faricimab - Proliferative Diabetic Retinopathy
Not applicableCompletedBojie Hu82024-12-012025-08-28
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
Conbercept - Retinopathy of Prematurity (ROP)
Not applicableRecruitingWang Yusheng1462024-11-292026-07-30
Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy
Conbercept - Diabetic Macular Edema
Phase 4Active not recruitingShanghai Eye Disease Prevention and Treatment Center582024-04-012025-05-30
Anti-VEGF in Real-world
Ranibizumab, Aflibercept, Conbercept - Neovascular Age-related Macular Edema, Diabetic Macular Edema
UnknownWenbin Wei10002022-01-012022-02-03
Evaluation of RC28-E Injection in Diabetic Macular Edema
intravitreal injection of RC28-E, Conbercept - Diabetic Macular Edema
Phase 2CompletedRemeGen Co., Ltd.1562021-03-172023-12-18
Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)
Conbercept and TA, Conbercept - Diabetes Mellitus, Type 2, Macular Edema
Not applicableUnknownZhongshan Ophthalmic Center, Sun Yat-sen University502020-11-122020-11-17
PRP vs PRP+IVC for Severe nPDR
Conbercept, Panretinal coagulation - Severe Nonproliferative Diabetic Retinopathy, Diabetic Retinopathy
Not applicableUnknownRuijin Hospital402019-01-182019-03-05
Safety and Effectiveness of Intravitreal Conbercept for Exudative Circumscribed Choroidal Haemangioma
conbercept - Circumscribed Choroidal Haemangioma
Early Phase 1UnknownSun Yat-sen University502018-06-062018-06-27
Conbercept for Polypoidal Choroidal Vasculopathy(START Study)
Conbercept - Polypoidal Choroidal Vasculopathy, Conbercept
CompletedPeking Union Medical College Hospital5002018-05-012022-02-08
Initial Versus Delayed PDT Combination With Conbercept in PCV
conbercept, Initial PDT, Delayed PDT - Polypoidal Choroidal Vasculopathy
Phase 4CompletedThe Eye Hospital of Wenzhou Medical University802017-01-012019-07-19
Intravitreal Conbercept After Vitrectomy
Conbercept - Early Proliferative Diabetic Retinopathy
Early Phase 1CompletedTianjin Medical University Eye Hospital502017-01-012019-04-30
Conbercept in Choroidal Neovascularization Secondary to Uveitis
Conbercept, sham - Choroidal Neovascularization, Uveitis
Phase 2UnknownChongqing Medical University402016-11-012016-10-17
Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration
Treat-and-Extend regimen, Pro Re Nata, Conbercept - Age-related Macular Degeneration
Phase 4UnknownXiaodong Sun1412016-09-012020-05-19
Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy
Conbercept - Proliferative Diabetic Retinopathy, Tractional Retinal Detachment
Phase 4CompletedRuijin Hospital1122016-07-012019-11-21
Intravitreal Conbercept for Idiopathic Choroidal Neovascularization
conbercept - Idiopathic Choroidal Neovascularization
Phase 2UnknownJiao Mingfei502016-06-012016-08-11
Head to Head Study of Anti-VEGF Treatment.
ranibizumab, Conbercept - Age-related Macular Degeneration
Phase 4CompletedNovartis Pharmaceuticals122016-01-132017-11-30
The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)
Conbercept - Polypoidal Choroidal Vasculopathy (PCV)
Phase 4UnknownChengdu Kanghong Biotech Co., Ltd.3002015-10-012017-07-19
Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal Haemangioma
conbercept - Circumscribed Choroidal Haemangioma
Early Phase 1UnknownSun Yat-sen University502014-08-282019-06-04
Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)
Conbercept, Sham injection, Laser - Diabetic Macular Edema
Phase 3UnknownChengdu Kanghong Biotech Co., Ltd.2482014-07-012016-01-06
Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion
Conbercept - Retinal Vein Occlusion
Phase 2UnknownChengdu Kanghong Biotech Co., Ltd.602012-05-012014-03-27

Showing 20 of 21. Sign in to see all of them.

Conditions studied

Polypoidal Choroidal Vasculopathy (3)  ·  Macular Degeneration (2)  ·  Retinal Vein Occlusion (2)  ·  Choroidal Neovascularization (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Diabetic Retinopathy (1)  ·  Macular Edema (1)  ·  Retinopathy of Prematurity (1)  ·  Uveitis (1)

Sponsors

Chengdu Kanghong Biotech Co., Ltd. (4)  ·  Ruijin Hospital (2)  ·  Sun Yat-sen University (2)  ·  Bojie Hu (1)  ·  Chongqing Medical University (1)  ·  Jiao Mingfei (1)  ·  Novartis Pharmaceuticals (1)  ·  Peking Union Medical College Hospital (1)  ·  RemeGen Co., Ltd. (1)  ·  Shanghai Eye Disease Prevention and Treatment Center (1)  ·  The Eye Hospital of Wenzhou Medical University (1)  ·  Tianjin Medical University Eye Hospital (1)  ·  Wang Yusheng (1)  ·  Wenbin Wei (1)  ·  Xiaodong Sun (1)

Countries

China (19)

Top investigators

Chenjin Jin, Ph.D. (2)  ·  Bingqian Liu, MD, PhD (1)  ·  Qiong Zhang, MD (1)  ·  Rong X Li, MD,PhD (1)  ·  Tao Sun (1)  ·  Wenbin Wei, MD (1)  ·  Xi Shen, MD (1)  ·  Xi Shen, PhD (1)  ·  Xiaodong Sun (1)  ·  Xiaoling Liu, Professor (1)  ·  Youxin Chen, Professor (1)

Results publications

PMID 21438852, PMID 23706949, PMID 28902334, PMID 29104958, PMID 29127949, PMID 34001667, PMID 35223882, PMID 35795633, PMID 37021018, PMID 39207600, PMID 40122579